- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01302548
The Effect Of Wound Irrigation With Irrisept™ Delivery System On Abscess Healing In Patients Presenting To The Emergency Department
THE EFFECT OF WOUND IRRIGATION WITH IRRISEPT™ Delivery System ON ABSCESS HEALING IN PATIENTS PRESENTING TO THE EMERGENCY DEPARTMENT
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32610
- Shands Hospital at the University of Florida
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Immunocompetent individuals 12 years of age or older with an uncomplicated abscess
- Patient must be able to answer questions and be medically stable as defined by the Emergency Department physician
- Patient must voluntarily participate in the study
Exclusion Criteria:Patients with any of the following are excluded:
- Currently receiving antibiotics or received antibiotics within last 72 hours
- Evidence of systemic infection (fever, aches, chills, nausea)
- Requires admission to the hospital for infection or for any other reason(s)
- Abscess caused by a human or animal bite
- Prior history of hypersensitivity or allergy to Chlorhexidine Gluconate (CHG)
- Immunodeficiency (Examples: HIV Positive, Crohns Disease, Systemic Lupus Erythematosus, Addison's disease, psoriasis, splenectomy, leukemia, cancer on chemotherapy)
- Currently on any immune-modifying medication (Examples: prednisone, antivirals)
- History of chronic skin infection (3 or more in the past year)
- Chronic medical problem, for example end-stage heart, liver, kidney, or lung disease, diabetes mellitus, peripheral vascular disease, history of organ transplant
- Mental illness including but not limited to substance abuse, dementia, schizophrenia or mentally handicapped or challenged
- Incarcerated
- Patient is pregnant or thinks she may be pregnant
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: IRRISEPT
Device containing sterile water and chlorhexidine gluconate (CHG)
|
Device containing sterile water and chlorhexidine gluconate (CHG)
|
Active Comparator: Usual Care
The usual care method will either be the saline irrigation or incision and drainage depending on the physicians discretion.
|
The usual care method will either be the saline irrigation or incision and drainage depending on the physicians discretion.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Abscess Healing Based on Abscess Measurement Scale
Time Frame: 48 hours
|
The abscess healing process will use two methods: 1) "usual method" includes saline irrigation and/or incision & drainage, and 2) the use of IRRISEPT solution. The Abscess Measurement Scale was measured using a centimeter ruler. Scale 8cm - 10cm = Severe 6cm - 8cm = Moderate/severe 4cm - 6cm = Moderate 2cm - 4cm = Mild/moderate 0cm - 2cm = Mild |
48 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Patients Prescribed Oral Antibiotics
Time Frame: 48 hours
|
Number of patients prescribed oral antibiotics
|
48 hours
|
Abscess Measurement Using a Abscess Measurement Scale in Methicillin-resistant Staphylococcus Aureus (MRSA) Positive Patients.
Time Frame: 48 hours
|
The Abscess Measurement Scale was measured using a centimeter ruler. Scale 8cm - 10cm = Severe 6cm - 8cm = Moderate/severe 4cm - 6cm = Moderate 2cm - 4cm = Mild/moderate 0cm - 2cm = Mild |
48 hours
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Richard F Petrik, MD, University of Florida
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20101227
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abscess
-
Inje UniversityPusan National University Yangsan HospitalCompletedCryptogenic Pyogenic Liver AbscessKorea, Republic of
-
Hospital Italiano de Buenos AiresUnknownLiver Transplant AbscessArgentina
-
Kaohsiung Veterans General Hospital.BayerCompletedLiver AbscessTaiwan
-
Manchester University NHS Foundation TrustUniversity of Liverpool; University of Birmingham; National Institute for Health... and other collaboratorsCompletedPerianal Abscess | Perianal Infections | Peri Rectal Abscess | Abscess; Anus | Abscess AnorectalUnited Kingdom
-
Kaiser PermanenteGenentech, Inc.CompletedAbdominal Abscess | Pelvic AbscessUnited States
-
Nanfang Hospital of Southern Medical UniversityRecruitingInfections | Abscess | Liver Abscess | Liver Abscess, PyogenicChina
-
Northwell HealthPediatric Surgical Research CollaborativeActive, not recruitingPilonidal Disease | Pilonidal Sinus Without Abscess | Pilonidal Cyst/Fistula | Pilonidal Cyst Without Abscess | Pilonidal Cyst and Sinus Without Abscess | Pilonidal Abscess | Pilonidal Sinus With Abscess | Pilonidal Dimple With Abscess | Pilonidal Fistula With Abscess | Pilonidal Sinus Infected | Pilonidal... and other conditionsUnited States
-
The Hospital for Sick ChildrenTerminated
-
Hannover Medical SchoolBayerCompletedAbscess, Intra-AbdominalGermany
-
Dow University of Health SciencesCompleted
Clinical Trials on IRRISEPT
-
Irrimax CorporationTerminatedAbscessUnited States
-
Irrimax CorporationTerminatedAbscess | Skin and Soft Tissue InfectionsUnited States
-
University of Kansas Medical CenterIrrimax CorporationNot yet recruiting
-
Northern Illinois Foot and Ankle SpecialistsIrrimax CorporationRecruitingOutcomes of Irrisept Irrigation as an Adjunctive Treatment in the Management of Diabetic Foot UlcersDiabetic Foot UlcerUnited States
-
Brett CristRecruiting
-
Yale UniversityIrrimax CorporationRecruitingUrinary Retention | Neurogenic BladderUnited States
-
Loma Linda UniversityIrrimax CorporationNot yet recruitingCesarean Section Complications | Cesarean Section; InfectionUnited States
-
Irrimax CorporationCompleted
-
Irrimax CorporationTerminatedSurgical Site InfectionUnited States
-
Orthopaedic Associates of Michigan, PCMercy HealthRecruitingRate of Positive Culture Growth for C.Acnes From Specimens Obtained From the Shoulders of Patients Undergoing Primary Shoulder ArthroplastyUnited States